Rodman & Renshaw Reiterates Market Outperform and PT of $6 on Sanuwave Health

Loading...
Loading...
Rodman & Renshaw reiterated its Market Outperform rating on Sanuwave Health
SNWV
. At the same time, the rating agency left its price target on the company's stock unchanged at $6. On Tuesday, SNWV closed the day at $3.40.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: ReiterationAnalyst RatingsRodman and Renshaw
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...